603811 诚意药业
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)6.38414.28815.58018.36320.260
总资产报酬率 ROA (%)4.1459.02010.62513.50515.101
投入资产回报率 ROIC (%)4.68610.17511.97015.85616.550

边际利润分析
销售毛利率 (%)69.71264.17768.42470.87573.846
营业利润率 (%)24.47825.89425.10528.60925.109
息税前利润/营业总收入 (%)25.66926.88725.53428.27425.384
净利润/营业总收入 (%)21.50624.12824.60924.67421.758

收益指标分析
经营活动净收益/利润总额(%)73.56168.55173.78380.89488.859
价值变动净收益/利润总额(%)22.73933.40026.32720.86711.773
营业外收支净额/利润总额(%)0.2980.088-0.359-0.524-0.777

偿债能力分析
流动比率 (X)0.9801.5101.6931.1661.242
速动比率 (X)0.7041.1691.2630.6920.717
资产负债率 (%)32.79536.78036.54024.47026.580
带息债务/全部投入资本 (%)22.93625.75427.34213.030--
股东权益/带息债务 (%)326.285279.585257.363656.046771.727
股东权益/负债合计 (%)204.184171.272173.186304.777272.433
利息保障倍数 (X)22.96427.71849.226-151.90854.263

营运能力分析
应收账款周转天数 (天)35.86336.46837.16636.9050.000
存货周转天数 (天)202.879170.442198.476210.4040.000